Rapid visualization of PD-L1 expression level in glioblastoma immune microenvironment via machine learning cascade-based Raman histopathology
Qing-Qing Zhou,Jingxing Guo,Ziyang Wang,Jianrui Li,Meng Chen,Qiang Xu,Lijun Zhu,Qing Xu,Qiang Wang,Hao Pan,Jing Pan,Yong Zhu,Ming Song,Xiaoxue Liu,Jiandong Wang,Zhiqiang Zhang,Longjiang Zhang,Yiqing Wang,Huiming Cai,Xiaoyuan Chen,Guangming Lu
DOI: https://doi.org/10.1016/j.jare.2023.12.002
IF: 12.822
2023-12-10
Journal of Advanced Research
Abstract:Research highlights • This study achieved label-free visualization of PD-L1 expression at tissue level for the first time. • MLC-Raman histopathology achieved an accuracy of 0.99 in classifying distinct PD-L1 expression cells in GBM IME. • MLC-Raman histopathology could identify glioma, CD8 + T cells, macrophages and normal cells. • The imaging results exhibited strong concordance with MxIF and traditional pathologists' scoring. • The entire process from signal collection to visualization could be completed within 30 minutes. Introduction Combination immunotherapy holds promise for improving survival in responsive glioblastoma (GBM) patients. Programmed death-ligand 1 (PD-L1) expression in immune microenvironment (IME) is the most important predictive biomarker for immunotherapy. Due to the heterogeneous distribution of PD-L1, post-operative histopathology fails to accurately capture its expression in residual tumors, making intra-operative diagnosis crucial for GBM treatment strategies. However, the current methods for evaluating the expression of PD-L1 are still time-consuming. Objective To overcome the PD-L1 heterogeneity and enable rapid, accurate, and label-free imaging of PD-L1 expression level in GBM IME at the tissue level. Methods We proposed a novel intra-operative diagnostic method, Machine Learning Cascade (MLC)-based Raman histopathology, which uses a coordinate localization system (CLS), hierarchical clustering analysis (HCA), support vector machine (SVM), and similarity analysis (SA). This method enables visualization of PD-L1 expression in glioma cells, CD8 + T cells, macrophages, and normal cells in addition to the tumor/normal boundary. The study quantified PD-L1 expression levels using the tumor proportion, combined positive, and cellular composition scores (TPS, CPS, and CCS, respectively) based on Raman data. Furthermore, the association between Raman spectral features and biomolecules was examined biochemically. Results The entire process from signal collection to visualization could be completed within 30 minutes. In an orthotopic glioma mouse model, the MLC-based Raman histopathology demonstrated a high average accuracy (0.990) for identifying different cells and exhibited strong concordance with multiplex immunofluorescence (84.31%) and traditional pathologists' scoring ( R 2 ≥ 0.9). Moreover, the peak intensities at 837 and 874 cm -1 showed a positive linear correlation with PD-L1 expression level. Conclusions This study introduced a new and extendable diagnostic method to achieve rapid and accurate visualization of PD-L1 expression in GBM IMB at the tissular level, leading to great potential in GBM intraoperative diagnosis for guiding surgery and post-operative immunotherapy. Graphical abstract Download : Download high-res image (165KB) Download : Download full-size image
multidisciplinary sciences